The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.

The treatment response to anti-angiogenic agents varies among cancer patients and predictive biomarkers are needed to identify patients with resistant cancer or guide the choice of anti-angiogenic treatment. We present "the Cancer Angiogenesis Co-Culture (CACC) assay", an in vitro Function...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sarah Line Bring Truelsen, Nabi Mousavi, Haoche Wei, Lucy Harvey, Rikke Stausholm, Erik Spillum, Grith Hagel, Klaus Qvortrup, Ole Thastrup, Henrik Harling, Harry Mellor, Jacob Thastrup
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5310916ac9324f84825d18d85b90f7db
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5310916ac9324f84825d18d85b90f7db
record_format dspace
spelling oai:doaj.org-article:5310916ac9324f84825d18d85b90f7db2021-12-02T20:05:11ZThe cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.1932-620310.1371/journal.pone.0253258https://doaj.org/article/5310916ac9324f84825d18d85b90f7db2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253258https://doaj.org/toc/1932-6203The treatment response to anti-angiogenic agents varies among cancer patients and predictive biomarkers are needed to identify patients with resistant cancer or guide the choice of anti-angiogenic treatment. We present "the Cancer Angiogenesis Co-Culture (CACC) assay", an in vitro Functional Precision Medicine assay which enables the study of tumouroid induced angiogenesis. This assay can quantify the ability of a patient-derived tumouroid to induce vascularization by measuring the induction of tube formation in a co-culture of vascular cells and tumoroids established from the primary colorectal tumour or a metastasis. Furthermore, the assay can quantify the sensitivity of patient-derived tumoroids to anti-angiogenic therapies. We observed that tube formation increased in a dose-dependent manner upon treatment with the pro-angiogenic factor vascular endothelial growth factor A (VEGF-A). When investigating the angiogenic potential of tumoroids from 12 patients we found that 9 tumoroid cultures induced a significant increase in tube formation compared to controls without tumoroids. In these 9 angiogenic tumoroid cultures the tube formation could be abolished by treatment with one or more of the investigated anti-angiogenic agents. The 3 non-angiogenic tumoroid cultures secreted VEGF-A but we observed no correlation between the amount of tube formation and tumoroid-secreted VEGF-A. Our data suggests that the CACC assay recapitulates the complexity of tumour angiogenesis, and when clinically verified, could prove a valuable tool to quantify sensitivity towards different anti-angiogenic agents.Sarah Line Bring TruelsenNabi MousaviHaoche WeiLucy HarveyRikke StausholmErik SpillumGrith HagelKlaus QvortrupOle ThastrupHenrik HarlingHarry MellorJacob ThastrupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0253258 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sarah Line Bring Truelsen
Nabi Mousavi
Haoche Wei
Lucy Harvey
Rikke Stausholm
Erik Spillum
Grith Hagel
Klaus Qvortrup
Ole Thastrup
Henrik Harling
Harry Mellor
Jacob Thastrup
The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
description The treatment response to anti-angiogenic agents varies among cancer patients and predictive biomarkers are needed to identify patients with resistant cancer or guide the choice of anti-angiogenic treatment. We present "the Cancer Angiogenesis Co-Culture (CACC) assay", an in vitro Functional Precision Medicine assay which enables the study of tumouroid induced angiogenesis. This assay can quantify the ability of a patient-derived tumouroid to induce vascularization by measuring the induction of tube formation in a co-culture of vascular cells and tumoroids established from the primary colorectal tumour or a metastasis. Furthermore, the assay can quantify the sensitivity of patient-derived tumoroids to anti-angiogenic therapies. We observed that tube formation increased in a dose-dependent manner upon treatment with the pro-angiogenic factor vascular endothelial growth factor A (VEGF-A). When investigating the angiogenic potential of tumoroids from 12 patients we found that 9 tumoroid cultures induced a significant increase in tube formation compared to controls without tumoroids. In these 9 angiogenic tumoroid cultures the tube formation could be abolished by treatment with one or more of the investigated anti-angiogenic agents. The 3 non-angiogenic tumoroid cultures secreted VEGF-A but we observed no correlation between the amount of tube formation and tumoroid-secreted VEGF-A. Our data suggests that the CACC assay recapitulates the complexity of tumour angiogenesis, and when clinically verified, could prove a valuable tool to quantify sensitivity towards different anti-angiogenic agents.
format article
author Sarah Line Bring Truelsen
Nabi Mousavi
Haoche Wei
Lucy Harvey
Rikke Stausholm
Erik Spillum
Grith Hagel
Klaus Qvortrup
Ole Thastrup
Henrik Harling
Harry Mellor
Jacob Thastrup
author_facet Sarah Line Bring Truelsen
Nabi Mousavi
Haoche Wei
Lucy Harvey
Rikke Stausholm
Erik Spillum
Grith Hagel
Klaus Qvortrup
Ole Thastrup
Henrik Harling
Harry Mellor
Jacob Thastrup
author_sort Sarah Line Bring Truelsen
title The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
title_short The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
title_full The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
title_fullStr The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
title_full_unstemmed The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
title_sort cancer angiogenesis co-culture assay: in vitro quantification of the angiogenic potential of tumoroids.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/5310916ac9324f84825d18d85b90f7db
work_keys_str_mv AT sarahlinebringtruelsen thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT nabimousavi thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT haochewei thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT lucyharvey thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT rikkestausholm thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT erikspillum thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT grithhagel thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT klausqvortrup thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT olethastrup thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT henrikharling thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT harrymellor thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT jacobthastrup thecancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT sarahlinebringtruelsen cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT nabimousavi cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT haochewei cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT lucyharvey cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT rikkestausholm cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT erikspillum cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT grithhagel cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT klausqvortrup cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT olethastrup cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT henrikharling cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT harrymellor cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
AT jacobthastrup cancerangiogenesiscocultureassayinvitroquantificationoftheangiogenicpotentialoftumoroids
_version_ 1718375480519819264